Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.
about
Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparison of effectiveness an ...... riority multiple center study.
@en
Comparison of effectiveness an ...... riority multiple center study.
@nl
type
label
Comparison of effectiveness an ...... riority multiple center study.
@en
Comparison of effectiveness an ...... riority multiple center study.
@nl
prefLabel
Comparison of effectiveness an ...... riority multiple center study.
@en
Comparison of effectiveness an ...... riority multiple center study.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of effectiveness an ...... riority multiple center study.
@en
P2093
M M Jablonski
P2860
P2888
P304
P356
10.1038/EYE.2017.187
P577
2017-09-22T00:00:00Z